![]() | ![]() |
Formats:
|
||||||||||||||||
Rate Dependence and Regulation of Action Potential and Calcium Transient in a Canine Cardiac Ventricular Cell Model From the Departments of Biomedical Engineering (T.J.H., Y.R.) and Pathology (T.J.H.), Washington University, St. Louis, Mo. Correspondence to Yoram Rudy, Department of Biomedical Engineering, Washington University, Campus Box 1097, One Brookings Dr, St. Louis, MO 63130-4899., E-mail rudy/at/wustl.edu The publisher's final edited version of this article is available free at Circulation. See other articles in PMC that cite the published article.Abstract Background Computational biology is a powerful tool for elucidating arrhythmogenic mechanisms at the cellular level, where complex interactions between ionic processes determine behavior. A novel theoretical model of the canine ventricular epicardial action potential and calcium cycling was developed and used to investigate ionic mechanisms underlying Ca2+ transient (CaT) and action potential duration (APD) rate dependence. Methods and Results The Ca2+/calmodulin-dependent protein kinase (CaMKII) regulatory pathway was integrated into the model, which included a novel Ca2+-release formulation, Ca2+ subspace, dynamic chloride handling, and formulations for major ion currents based on canine ventricular data. Decreasing pacing cycle length from 8000 to 300 ms shortened APD primarily because of ICa(L) reduction, with additional contributions from Ito1, INaK, and late INa. CaT amplitude increased as cycle length decreased from 8000 to 500 ms. This positive rate–dependent property depended on CaMKII activity. Conclusions CaMKII is an important determinant of the rate dependence of CaT but not of APD, which depends on ion-channel kinetics. The model of CaMKII regulation may serve as a paradigm for modeling effects of other regulatory pathways on cell function. Keywords: electrophysiology, action potentials, calcium, ion channels The dependence of action potential duration (APD) and the Ca2+ transient (CaT) on pacing rate is a fundamental property of cardiac myocytes that, when altered, may promote life-threatening cardiac arrhythmias. We have developed a detailed and physiologically based mathematical canine ventricular cell model (Hund-Rudy dynamic [HRd] cell model) that simulates rate-dependent phenomena associated with ion-channel kinetics, AP properties, and Ca handling. The dog is commonly used to investigate cardiac electrophysiology, making it a logical choice for modeling. An epicardial myocyte was chosen rather than endocardial or midmyocardial myocytes because epicardial cells contain the highest density of Ito1 (transient outward K+ current), producing a unique and complex AP morphology. Ca2+/calmodulin-dependent protein kinase1 (CaMKII) mediates an important regulatory pathway in myocytes.2 On activation by Ca2+/calmodulin, CaMKII phosphorylates neighboring subunits (autophosphorylation), which enables detection of Ca2+ spike frequency.3 In cardiomyocytes, CaMKII substrates include L-type Ca2+ channels (LTCCs), ryanodine receptor Ca2+-release channels (RyRs), sarcoplasmic reticulum Ca2+-ATPase (SR Ca2+-uptake pump), and phospholamban (PLB).4–10 This suggests an important role for CaMKII in cardiac Ca2+-handling rate dependence and electrophysiology. We used the HRd model to gain new insights into ionic processes underlying AP and CaT rate dependence and how CaMKII regulates these processes. Methods Complete HRd equations, definitions, and detailed comments appear in the online-only Data Supplement. Important model properties (schematic in Figure 1A
Ca2+/Calmodulin-Dependent Protein Kinase II The CaMKII formulation was adapted from Hanson et al3 and responds dynamically to [Ca2+]ss (subspace Ca2+ concentration) elevation during the CaT. Kinase subunits can be inactive, in a Ca2+/calmodulin-bound active state (CaMKbound), or in a “trapped” state (CaMKtrap), wherein the subunit remains active for some time after [Ca2+]ss returns to diastolic values. Autophosphorylation of 1 subunit by another promotes transition from CaMKbound to CaMKtrap. Trapped subunits are dephosphorylated at a constant rate, βCaMK, of 0.00068 ms−1, a moderate value compared with the cycle-length (CL) range investigated here. Subspace Compartment The junctional SR membrane abuts the sarcolemma along t-tubules, where LTCC and RyR clusters are localized,11 creating a subspace in which the Ca2+ concentration ([Ca2+]ss) rises faster and reaches larger values compared with that of the bulk myoplasm. We modeled the subspace as a compartment into which LTCCs and RyRs open, generating a local Ca2+ concentration, [Ca2+]ss. Anionic sarcolemmal and SR membrane binding sites act as calcium buffers.12 The Ca2+-dependent transient outward current (Ito2) is a ligand-gated Cl−-selective channel. Its low Ca2+ sensitivity (K0.5 = 0.1502 mmol/L)13 supports its incorporation into the Ca2+ subspace. CaMKII forms a complex with RyR14 and is also assumed to be in the subspace. RyR Ca2+-Release Channel Irel The Irel formulation includes activation by the L-type Ca2+ current, Ca2+-dependent inactivation,15,16 and open-probability modulation by junctional SR [Ca2+] and [Ca2+]ss17. Although it is generally accepted that the RyR is regulated by SR Ca2+ content17 and inactivated by cytosolic Ca,15,16 the relative contribution of each process to SR Ca2+-release termination is unknown. Irel in our formulation terminates via both inactivation and SR regulation of the activation gate.18 Graded release is achieved by making steady-state activation a continuous function of ICa(L). Voltage-dependent SR release gain19 (variable gain, Figure 1B Though controversial (online-only Data Supplement section J), CaMKII phosphorylation is thought to promote RyR channel opening.5,14,20 Accordingly, the Irel inactivation time constant (τri) depends on CaMKII activity. A 10-ms maximal CaMKII-dependent increase in τri yields a steady-state CaT amplitude (CaTamp) 95%20 greater for control than with CaMKII suppressed at rapid pacing (CL = 300 ms). SR Ca2+-ATPase and PLB CaMKII phosphorylates the SR,6 targeting SERCA2a
(SR Ca2+-ATPase)7 and PLB,8,10 which associates
with SERCA2a to inhibit uptake. PLB phosphorylation shifts the Ca2+-binding
K0.5 and relieves inhibition,9
whereas direct SERCA2a phosphorylation increases the maximum uptake rate,7 although this is controversial9 (online-only Data Supplement section K). Uptake and
K0.5 depend on CaMKII activity to represent this behavior. The
maximal CaMKII-dependent increase in uptake is 75%,7 whereas the maximal K0.5 decrease is 0.17 μmol/L9. L-Type Ca2+ Channel ICa(L) steady-state activation and current density yield a current-voltage (I–V) relation consistent with canine ventricular data21 (Figure 1C Two Components of the Delayed Rectifier K+ Current The canine delayed rectifier K+ current has a rapidly activating component (IKr) and a slowly activating component (IKs).24 The model IKs has fast (xs1, with time constant τxs1) and slow (xs2) activation gates. Voltage dependence of τxs1 fits canine data.24 The slow activation gate is 10 times slower than xs124. IKr has 1 activation gate, xr, based on experimental data.24 IKs and IKr conductances were chosen to agree with experimental data24 (Figure 1E Transient Outward K+ Current Other Formulations Cl Homeostasis Na+-Ca2+ Exchanger The Na+-Ca2+ exchanger (INaCa), from Weber et al,30 includes an allosteric interaction between intracellular Ca2+ and the exchanger. Pacing Studies The model was paced with a conservative current stimulus34 (carried by KCl) for 2000 seconds from rest (initial conditions in online-only Data Supplement Table II) at a constant CL. Steady-state APD (at 90% repolarization) and CaTamp (peak systolic [Ca2+]i–minimal diastolic [Ca2+]i) were used to create the APD adaptation curves and the CaTamp-frequency curves, respectively. Results APD Rate Dependence (Adaptation) The model AP morphology (Figure 2A
Interestingly, a decrease in the repolarizing current Ito1 facilitates APD shortening at a fast rate. Comparing steady-state AP with (= 0.19 mS/μF) and without (= 0 mS/μF) Ito1 reveals the effect of Ito1 on APD (Figure 3
Figure 4
CaTamp-Frequency Relation Steady-state CaTamp and morphology (Figure 5A
Discussion We present a dynamic model of the canine ventricular epicardial cell that reproduces experimentally measured AP and CaT over a wide pacing frequency range. Given the broad frequency range during cardiac arrhythmias and the interplay between Ca cycling and cellular electrophysiology in arrhythmogenesis, this model serves as a valuable research tool. Summary of Important Mechanistic Findings The major findings of this study are that (1) canine APD adaptation is determined primarily by ICa(L) reduction at fast rates; (2) Ito1 contributes to APD adaptation indirectly by augmenting the phase 1 notch at slow rate; (3) ECC gain increases with frequency owing to increased CaMKII activity, producing a positive CaTamp-frequency relation; and (4) CaMKII is important for rate-dependent changes in CaT but does not significantly effect APD adaptation. Comparison With Existing Models Canine ventricular AP models have been previously developed to study electrophysiologic remodeling after heart failure37 and myocardial infarction38 and APD alternans during rapid pacing.39 The model presented here distinguishes itself by incorporating (1) dynamic CaMKII activity and regulation of intracellular Ca2+ handling; (2) the late Na+ current, INa,L, and the Ca2+-dependent transient outward current, Ito2; (3) dynamic intracellular Cl+ concentration changes; and (4) a novel Irel formulation. Our model represents an important advance in the physiologic representation of rate-dependent cell processes through its inclusion of the CaMKII regulatory pathway, shown experimentally to play a role in the force-frequency relation and rate-dependent CaT abbreviation.14,20,40 “Local-control”41 Ca2+ release has been integrated into a canine AP model,42 wherein SR Ca2+ release involves statistical recruitment of individual Ca2+ release units. Although this model reproduces macroscopic release based on individual diadic events, computational demands discourage its use in modeling cardiac arrhythmias. Therefore, we reproduced local-control features (variable gain and graded release) by using a macroscopic approach with reduced computational demand. Effect of CaMKII on Ca2+ Handling We have shown that increased CaMKII activity during rapid pacing augments SR Ca2+ release and promotes a positive CaTamp-frequency relation. Our findings are supported by recent experiments measuring increased CaMKII activity and CaMKII-dependent SR Ca2+ release after pacing.14 It is important to note that additional factors determine the CaTamp-frequency relation. Even in the presence of CaMKII inhibition, a positive relation exists over a limited frequency range from 0.125 to 1 Hz (see Figure 5B APD Adaptation In the guinea pig, IKs activates and deactivates more slowly than does IKr44. In the dog, IKr and IKs deactivation kinetics are reversed, with IKs deactivating faster than IKr.24 Our simulations suggest that IKs does not contribute significantly to canine APD adaptation owing to its small amplitude and fast deactivation, consistent with recent canine experiments.45,46 However, β-adrenergic stimulation enhances IKs,47 possibly increasing its importance in AP repolarization and adaptation in vivo. Our results also suggest a role for Ito1 in determining APD and APD adaptation. Consistent with previous theoretical48 and experimental49 studies, we found that Ito1 creates a phase 1 notch that increases the driving force for ICa(L) and facilitates activation of a sustained component. In addition, the phase 1 notch decreases the repolarizing currents IKr and reverse-mode INaCa. Together, these processes prolong APD. New insight is obtained into the role of Ito1 in APD adaptation: slow recovery promotes Ito1 reduction, notch suppression, and less associated APD prolongation at fast rates. Our findings are consistent with greater adaptation in epicardial than in endocardial cells (85 and 65 ms, respectively26), which have a greatly diminished Ito1 density. We also found (not shown) that the notch accelerates the time to peak CaT (62 ms in control vs 83 ms without Ito1), consistent with experimental observations.50 Limitations The model formulation was based, wherever possible, on recent experimental data and current understanding of cardiac electrophysiology and Ca2+ handling. However, there are controversies regarding CaMKII and its regulatory effects. Disparate findings exist on whether or not CaMKII phosphorylates SERCA2a directly.7,9 Similarly, conflicting reports exist on CaMKII regulation of RyR activity.5,20,51,52 These issues remain unresolved (see online-only Data Supplement, sections J and K). We hope that this study will motivate detailed experimental characterization of CaMKII effects on cellular function. supplement Click here to view.(183K, pdf) Acknowledgments This work was funded by grants R01-HL49054 and R37-HL33343 (to Y.R.) from the National Institutes of Health—National Heart, Lung, and Blood Institute, and a Whitaker Foundation Development Award. We thank Greg Faber, Jonathan Silva, and Keith Decker for helpful discussions and Marlene Siegal for administrative assistance. Footnotes An online-only Data Supplement is available at http://www.circulationaha.org References 1. Braun AP, Schulman H. The multifunctional calcium/calmodulin-dependent protein kinase: from form to function. Annu Rev Physiol. 1995;57:417–445. [PubMed] 2. Maier LS, Bers DM. Calcium, calmodulin, and calcium-calmodulin kinase II: heartbeat to heartbeat and beyond. J Mol Cell Cardiol. 2002;34:919–939. [PubMed] 3. Hanson PI, Meyer T, Stryer L, Schulman H. Dual role of calmodulin in autophosphorylation of multifunctional CaM kinase may underlie decoding of calcium signals. Neuron. 1994;12:943–956. [PubMed] 4. Yuan W, Bers DM. Ca-dependent facilitation of cardiac Ca current is due to Ca-calmodulin-dependent protein kinase. Am J Physiol Heart Circ Physiol. 1994;267:H982–H993. 5. Witcher DR, Kovacs RJ, Schulman H, Cefali DC, Jones LR. Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity. J Biol Chem. 1991;266:11144–11152. [PubMed] 6. Le Peuch CJ, Haiech J, Demaille JG. Concerted regulation of cardiac sarcoplasmic reticulum calcium transport by cyclic adenosine monophosphate-dependent and calcium/calmodulin-dependent phosphorylations. Biochemistry. 1979;18:5150–5157. [PubMed] 7. Toyofuku T, Curotto Kurzydlowski K, Narayanan N, MacLennan DH. Identification of Ser38 as the site in cardiac sarcoplasmic reticulum Ca2+-ATPase that is phosphorylated by Ca2+/calmodulin-dependent protein kinase. J Biol Chem. 1994;269:26492–26496. [PubMed] 8. Wegener AD, Simmerman HK, Lindemann JP, Jones LR. Phospholamban phosphorylation in intact ventricles: phosphorylation of serine 16 and threonine 17 in response to β-adrenergic stimulation. J Biol Chem. 1989;264:11468–11474. [PubMed] 9. Odermatt A, Kurzydlowski K, MacLennan DH. The vmax of the Ca2+-ATPase of cardiac sarcoplasmic reticulum (SERCA2a) is not altered by Ca2+/calmodulin-dependent phosphorylation or by interaction with phospholamban. J Biol Chem. 1996;271:14206–14213. [PubMed] 10. Hagemann D, Kuschel M, Kuramochi T, Zhu W, Cheng H, Xiao RP. Frequency-encoding Thr17 phospholamban phosphorylation is independent of Ser16 phosphorylation in cardiac myocytes. J Biol Chem. 2000;275:22532–22536. [PubMed] 11. Langer G, Peskoff A. Calcium concentration and movement in the diadic cleft space of the cardiac ventricular cell. Biophys J. 1996;70:1169–1182. [PubMed] 12. Smith G, Keizer J, Stern M, Lederer W, Cheng H. A simple numerical model of calcium spark formation and detection in cardiac myocytes. Biophys J. 1998;75:15–32. [PubMed] 13. Collier ML, Levesque PC, Kenyon JL, Hume JR. Unitary Cl− channels activated by cytoplasmic Ca2+ in canine ventricular myocytes. Circ Res. 1996;78:936–944. [PubMed] 14. Wehrens XH, Lehnart SE, Reiken SR, Marks AR. Ca2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circ Res. 2004;94:e61–e70. [PubMed] 15. Sham J, Song L, Chen Y, Deng L, Stern M, Lakatta E, Cheng H. Termination of Ca2+ release by a local inactivation of ryanodine receptors in cardiac myocytes. Proc Natl Acad Sci U S A. 1998;95:15096–15101. [PubMed] 16. Fabiato A. Time and calcium dependence of activation and inactivation of calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned canine cardiac Purkinje cell. J Gen Physiol. 1985;85:247–289. [PubMed] 17. Lukyanenko V, Gyorke I, Gyorke S. Regulation of calcium release by calcium inside the sarcoplasmic reticulum in ventricular myocytes. Pflugers Arch. 1996;432:1047–1054. [PubMed] 18. Shannon TR, Guo T, Bers DM. Ca2+ scraps: local depletions of free [Ca2+] in cardiac sarcoplasmic reticulum during contractions leave substantial Ca2+ reserve. Circ Res. 2003;93:40–45. [PubMed] 19. Wier WG, Egan TM, Lopez Lopez JR, Balke CW. Local control of excitation-contraction coupling in rat heart cells. J Physiol (Lond). 1994;474:463–471. [PubMed] 20. Li L, Satoh H, Ginsburg KS, Bers DM. The effect of Ca2+-calmodulin-dependent protein kinase II on cardiac excitation-contraction coupling in ferret ventricular myocytes. J Physiol (Lond). 1997;501:17–31. [PubMed] 21. Rubart M, Lopshire JC, Fineberg NS, Zipes DP. Changes in left ventricular repolarization and ion channel currents following a transient rate increase superimposed on bradycardia in anesthetized dogs. J Cardiovasc Electrophysiol. 2000;11:652–664. [PubMed] 21a. Aggarwal R, Boyden PA. Diminished Ca2+ and Ba2+ currents in myocytes surviving in the epicardial border zone of the 5-day infarcted canine heart. Circ Res. 1995;77:1180–1191. [PubMed] 22. Sun H, Leblanc N, Nattel S. Mechanisms of inactivation of L-type calcium channels in human atrial myocytes. Am J Physiol Heart Circ Physiol. 1997;272:H1625–H1635. 23. Hirano Y, Hiraoka M. Ca2+ entry-dependent inactivation of L-type Ca current: a novel formulation for cardiac action potential models. Biophys J. 2003;84:696–708. [PubMed] 24. Liu DW, Antzelevitch C. Characteristics of the delayed rectifier current (IKr and IKs) in canine ventricular epicardial, midmyocardial, and endocardial myocytes: a weaker IKs contributes to the longer action potential of the M cell. Circ Res. 1995;76:351–365. [PubMed] 25. Dumaine R, Towbin JA, Brugada P, Vatta M, Nesterenko DV, Nesterenko VV, Brugada J, Brugada R, Antzelevitch C. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res. 1999;85:803–809. [PubMed] 26. Liu DW, Gintant GA, Antzelevitch C. Ionic bases for electrophysiological distinctions among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle. Circ Res. 1993;72:671–687. [PubMed] 27. Lue WM, Boyden PA. Abnormal electrical properties of myocytes from chronically infarcted canine heart: alterations in Vmax and the transient outward current. Circulation. 1992;85:1175–1188. [PubMed] 28. Kneller J, Ramirez RJ, Chartier D, Courtemanche M, Nattel S. Time-dependent transients in an ionically based mathematical model of the canine atrial action potential. Am J Physiol Heart Circ Physiol. 2002;282:H1437–H1451. [PubMed] 29. Piwnica-Worms D, Jacob R, Horres CR, Lieberman M. Potassium-chloride cotransport in cultured chick heart cells. Am J Physiol Cell Physiol. 1985;249:C337–C344. 30. Weber CR, Ginsburg KS, Philipson KD, Shannon TR, Bers DM. Allosteric regulation of Na/Ca exchange current by cytosolic Ca in intact cardiac myocytes. J Gen Physiol. 2001;117:119–131. [PubMed] 31. Zygmunt AC, Eddlestone GT, Thomas GP, Nesterenko VV, Antzelevitch C. Larger late sodium conductance in M cells contributes to electrical heterogeneity in canine ventricle. Am J Physiol Heart Circ Physiol. 2001;281:H689–H697. [PubMed] 32. Luo CH, Rudy Y. A dynamic model of the cardiac ventricular action potential, I: simulations of ionic currents and concentration changes. Circ Res. 1994;74:1071–1096. [PubMed] 33. Maltsev VA, Sabbah HN, Undrovinas AI. Late sodium current is a novel target for amiodarone: studies in failing human myocardium. J Mol Cell Cardiol. 2001;33:923–932. [PubMed] 34. Hund TJ, Kucera JP, Otani NF, Rudy Y. Ionic charge conservation and long-term steady state in the Luo-Rudy dynamic model of the cardiac cell. Biophys J. 2001;81:3324–3331. [PubMed] 35. Viswanathan P, Shaw R, Rudy Y. Effects of IKr and IKs heterogeneity on action potential duration and its rate dependence: a simulation study. Circulation. 1999;99:2466–2474. [PubMed] 36. Sipido KR, Volders PG, de Groot SH, Verdonck F, Van de Werf F, Wellens HJ, Vos MA. Enhanced Ca2+ release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes: potential link between contractile adaptation and arrhythmogenesis. Circulation. 2000;102:2137–2144. [PubMed] 37. Winslow RL, Rice J, Jafri S, Marbán E, O’Rourke B. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, II: model studies. Circ Res. 1999;84:571–586. [PubMed] 38. Cabo C, Boyden P. Electrical remodeling of the epicardial border zone in the canine infarcted heart: a computational analysis. Am J Physiol Heart Circ Physiol. 2003;284:H372–H384. [PubMed] 39. Fox JJ, McHarg JL, Gilmour RF., Jr Ionic mechanism of electrical alternans. Am J Physiol Heart Circ Physiol. 2002;282:H516–H530. [PubMed] 40. Bassani RA, Mattiazzi A, Bers DM. CaMKII is responsible for activity-dependent acceleration of relaxation in rat ventricular myocytes. Am J Physiol Heart Circ Physiol. 1995;268:H703–H712. 41. Stern M. Theory of excitation-contraction coupling in cardiac muscle. Biophys J. 1992;63:497–517. [PubMed] 42. Greenstein JL, Winslow RL. An integrative model of the cardiac ventricular myocyte incorporating local control of Ca2+ release. Biophys J. 2002;83:2918–2945. [PubMed] 43. Kuratomi S, Matsuoka S, Sarai N, Powell T, Noma A. Involvement of Ca2+ buffering and Na+/Ca2+ exchange in the positive staircase of contraction in guinea-pig ventricular myocytes. Pflugers Arch. 2003;446:347–355. [PubMed] 44. Sanguinetti MC, Jurkiewicz NK. Two components of cardiac delayed rectifier K+ current: differential sensitivity to block by class III antiar-rhythmic agents. J Gen Physiol. 1990;96:195–215. [PubMed] 45. Varro A, Balati B, Iost N, Takacs J, Virag L, Lathrop DA, Csaba L, Talosi L, Papp JG. The role of the delayed rectifier component IKs in dog ventricular muscle and Purkinje fibre repolarization. J Physiol (Lond). 2000;523:67–81. [PubMed] 46. Stengl M, Volders PG, Thomsen MB, Spatjens RL, Sipido KR, Vos MA. Accumulation of slowly activating delayed rectifier potassium current (IKs) in canine ventricular myocytes. J Physiol (Lond). 2003;551:777–786. [PubMed] 47. Sanguinetti MC, Jurkiewicz NK, Scott A, Siegl PK. Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes: mechanism of action. Circ Res. 1991;68:77–84. [PubMed] 48. Greenstein JL, Wu R, Po S, Tomaselli GF, Winslow RL. Role of the calcium-independent transient outward current Ito1 in shaping action potential morphology and duration. Circ Res. 2000;87:1026–1033. [PubMed] 49. Banyasz T, Fulop L, Magyar J, Szentandrassy N, Varro A, Nanasi PP. Endocardial versus epicardial differences in L-type calcium current in canine ventricular myocytes studied by action potential voltage clamp. Cardiovasc Res. 2003;58:66–75. [PubMed] 50. Cordeiro JM, Greene L, Heilmann C, Antzelevitch D, Antzelevitch C. Transmural heterogeneity of calcium activity and mechanical function in the canine left ventricle. Am J Physiol Heart Circ Physiol. 2004;286:H1471–H1479. [PubMed] 51. Lokuta AJ, Rogers TB, Lederer WJ, Valdivia HH. Modulation of cardiac ryanodine receptors of swine and rabbit by a phosphorylation-dephosphorylation mechanism. J Physiol (Lond). 1995;487:609–622. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
Annu Rev Physiol. 1995; 57():417-45.
[Annu Rev Physiol. 1995]J Mol Cell Cardiol. 2002 Aug; 34(8):919-39.
[J Mol Cell Cardiol. 2002]Neuron. 1994 May; 12(5):943-56.
[Neuron. 1994]J Biol Chem. 2000 Jul 21; 275(29):22532-6.
[J Biol Chem. 2000]Neuron. 1994 May; 12(5):943-56.
[Neuron. 1994]Biophys J. 1996 Mar; 70(3):1169-82.
[Biophys J. 1996]Biophys J. 1998 Jul; 75(1):15-32.
[Biophys J. 1998]Circ Res. 1996 May; 78(5):936-44.
[Circ Res. 1996]Circ Res. 2004 Apr 2; 94(6):e61-70.
[Circ Res. 2004]Proc Natl Acad Sci U S A. 1998 Dec 8; 95(25):15096-101.
[Proc Natl Acad Sci U S A. 1998]J Gen Physiol. 1985 Feb; 85(2):247-89.
[J Gen Physiol. 1985]Pflugers Arch. 1996 Oct; 432(6):1047-54.
[Pflugers Arch. 1996]Circ Res. 2003 Jul 11; 93(1):40-5.
[Circ Res. 2003]J Physiol. 1994 Feb 1; 474(3):463-71.
[J Physiol. 1994]J Biol Chem. 1991 Jun 15; 266(17):11144-52.
[J Biol Chem. 1991]Circ Res. 2004 Apr 2; 94(6):e61-70.
[Circ Res. 2004]J Physiol. 1997 May 15; 501 ( Pt 1)():17-31.
[J Physiol. 1997]Biochemistry. 1979 Nov 13; 18(23):5150-7.
[Biochemistry. 1979]J Biol Chem. 1994 Oct 21; 269(42):26492-6.
[J Biol Chem. 1994]J Biol Chem. 1989 Jul 5; 264(19):11468-74.
[J Biol Chem. 1989]J Biol Chem. 2000 Jul 21; 275(29):22532-6.
[J Biol Chem. 2000]J Biol Chem. 1996 Jun 14; 271(24):14206-13.
[J Biol Chem. 1996]J Cardiovasc Electrophysiol. 2000 Jun; 11(6):652-64.
[J Cardiovasc Electrophysiol. 2000]Circ Res. 1995 Dec; 77(6):1180-91.
[Circ Res. 1995]Biophys J. 2003 Jan; 84(1):696-708.
[Biophys J. 2003]J Physiol. 1997 May 15; 501 ( Pt 1)():17-31.
[J Physiol. 1997]Circ Res. 1995 Mar; 76(3):351-65.
[Circ Res. 1995]Circ Res. 1999 Oct 29; 85(9):803-9.
[Circ Res. 1999]Circ Res. 1993 Mar; 72(3):671-87.
[Circ Res. 1993]Circulation. 1992 Mar; 85(3):1175-88.
[Circulation. 1992]Am J Physiol Heart Circ Physiol. 2002 Apr; 282(4):H1437-51.
[Am J Physiol Heart Circ Physiol. 2002]J Gen Physiol. 2001 Feb; 117(2):119-31.
[J Gen Physiol. 2001]Am J Physiol Heart Circ Physiol. 2001 Aug; 281(2):H689-97.
[Am J Physiol Heart Circ Physiol. 2001]Circ Res. 1994 Jun; 74(6):1071-96.
[Circ Res. 1994]J Mol Cell Cardiol. 2001 May; 33(5):923-32.
[J Mol Cell Cardiol. 2001]Biophys J. 2001 Dec; 81(6):3324-31.
[Biophys J. 2001]Circ Res. 1993 Mar; 72(3):671-87.
[Circ Res. 1993]Circ Res. 1994 Jun; 74(6):1071-96.
[Circ Res. 1994]Circulation. 1999 May 11; 99(18):2466-74.
[Circulation. 1999]Circulation. 2000 Oct 24; 102(17):2137-44.
[Circulation. 2000]Circ Res. 1999 Mar 19; 84(5):571-86.
[Circ Res. 1999]Am J Physiol Heart Circ Physiol. 2003 Jan; 284(1):H372-84.
[Am J Physiol Heart Circ Physiol. 2003]Am J Physiol Heart Circ Physiol. 2002 Feb; 282(2):H516-30.
[Am J Physiol Heart Circ Physiol. 2002]Circ Res. 2004 Apr 2; 94(6):e61-70.
[Circ Res. 2004]J Physiol. 1997 May 15; 501 ( Pt 1)():17-31.
[J Physiol. 1997]Biophys J. 1992 Aug; 63(2):497-517.
[Biophys J. 1992]Biophys J. 2002 Dec; 83(6):2918-45.
[Biophys J. 2002]Circ Res. 2004 Apr 2; 94(6):e61-70.
[Circ Res. 2004]Pflugers Arch. 2003 Jun; 446(3):347-55.
[Pflugers Arch. 2003]J Gen Physiol. 1990 Jul; 96(1):195-215.
[J Gen Physiol. 1990]J Physiol. 2000 Feb 15; 523 Pt 1():67-81.
[J Physiol. 2000]J Physiol. 2003 Sep 15; 551(Pt 3):777-86.
[J Physiol. 2003]Circ Res. 1991 Jan; 68(1):77-84.
[Circ Res. 1991]Circ Res. 2000 Nov 24; 87(11):1026-33.
[Circ Res. 2000]Cardiovasc Res. 2003 Apr 1; 58(1):66-75.
[Cardiovasc Res. 2003]Circ Res. 1993 Mar; 72(3):671-87.
[Circ Res. 1993]Am J Physiol Heart Circ Physiol. 2004 Apr; 286(4):H1471-9.
[Am J Physiol Heart Circ Physiol. 2004]J Biol Chem. 1994 Oct 21; 269(42):26492-6.
[J Biol Chem. 1994]J Biol Chem. 1996 Jun 14; 271(24):14206-13.
[J Biol Chem. 1996]J Physiol. 1994 Feb 1; 474(3):463-71.
[J Physiol. 1994]J Cardiovasc Electrophysiol. 2000 Jun; 11(6):652-64.
[J Cardiovasc Electrophysiol. 2000]Circ Res. 1995 Mar; 76(3):351-65.
[Circ Res. 1995]Circulation. 1992 Mar; 85(3):1175-88.
[Circulation. 1992]Circ Res. 1995 Mar; 76(3):351-65.
[Circ Res. 1995]Circ Res. 1993 Mar; 72(3):671-87.
[Circ Res. 1993]Circ Res. 1994 Jun; 74(6):1071-96.
[Circ Res. 1994]Circulation. 2000 Oct 24; 102(17):2137-44.
[Circulation. 2000]J Biol Chem. 2000 Jul 21; 275(29):22532-6.
[J Biol Chem. 2000]